← All Sponsors
SPONSOR

Universiti Sains Malaysia

Total Trials
2
Recruiting
2
Phases
Phase 2

Universiti Sains Malaysia is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Diabetic Polyneuropathy, Healthy Adults.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Universiti Sains Malaysia

How many clinical trials has Universiti Sains Malaysia sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Universiti Sains Malaysia, of which 2 are actively recruiting participants. These trials cover conditions including Diabetic Polyneuropathy, Healthy Adults. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universiti Sains Malaysia research focus on?
Universiti Sains Malaysia clinical trials span Diabetic Polyneuropathy, Healthy Adults. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universiti Sains Malaysia clinical trial?
To participate in a Universiti Sains Malaysia trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universiti Sains Malaysia trials with current recruitment status updated daily.

Clinical Trials by Universiti Sains Malaysia

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology